CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Friedman Aviad Director | Gift | −6,000 | 0 | ||
| 2022-01-03 | Friedman Aviad Director | Grant or award · Stock Option (right to buy | +10,000 | 10,000 | ||
| 2022-01-03 | Friedman Aviad Director | Gift · Stock Option (right to buy | −10,000 | 0 | ||
| 2021-12-30 | KIDRON NADAV President and CEO | Gift | −20,000 | 766,481 | ||
| 2021-12-28 | KIDRON NADAV President and CEO | Shares withheld for taxes | −31,728 | $12.98 | $412K | 786,481 |
| 2021-12-28 | Rabinowitz Michael Chief Commercial Officer | Shares withheld for taxes | −9,532 | $12.98 | $124K | 90,468 |
| 2021-12-16 | RAKIN KEVIN Director | Gift | −5,000 | 52,004 | ||
| 2021-12-03 | KIDRON NADAV President and CEO | Gift | −20,000 | 818,209 | ||
| 2021-11-01 | Mayer Arie Director | Sale | −3,000 | $25.60 | $77K | 0 |
| 2021-09-16 | RAKIN KEVIN Director | Sale | −21,100 | $20.99 | $443K | 57,004 |
| 2021-09-01 | Silberman David Chief Financial Officer | Grant or award | +50,000 | 50,000 | ||
| 2021-09-01 | Silberman David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-08-31 | KIDRON NADAV President and CEO | Grant or award | +100,000 | 838,209 | ||
| 2021-08-31 | Kidron Miriam Chief Scientific Officer | Grant or award | +66,666 | 141,666 | ||
| 2021-08-31 | Hexter Joshua Chief Operating & BO | Grant or award | +33,333 | 103,333 | ||
| 2021-08-31 | RAKIN KEVIN Director | Grant or award | +10,000 | 78,104 | ||
| 2021-08-31 | KIDRON NADAV President and CEO | Grant or award | +100,000 | 748,573 | ||
| 2021-08-09 | KIDRON NADAV President and CEO | Sale | −220,000 | $20.11 | $4.4M | 738,209 |
| 2021-08-09 | RAKIN KEVIN Director | Option exercise | +5,697 | $6.23 | $35K | 20,758 |
| 2021-08-09 | RAKIN KEVIN Director | Shares withheld for taxes | −1,683 | $21.09 | $35K | 19,075 |
Page 11 of 18 · 349 trades